Literature DB >> 25635624

The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function.

Valentina Romano1, Zainuddin Quadri, Francisco E Baralle, Emanuele Buratti.   

Abstract

Nuclear factor TDP-43 has been shown to play a key role in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia, where TDP-43 aggregates accumulate in patient's affected neurons and this event can cause neuronal dysfunction. A major focus of today's research is to discover the critical factors that lead to TDP-43 aggregation and the consequences for neuronal metabolism. From a structural point of view, several lines of evidence point toward TDP-43 C-terminus as a key domain able to mediate this process. Regarding this region, we have recently described a novel cellular TDP-43 aggregation model based on 12 tandem repetitions of its 339-366 Q/N rich prion-like domain. In addition, we have shown and confirmed that a minimal TDP-43 construct constituted by the N and C-terminal regions, but lacking both RRM domains, induce aggregation of endogenous TDP-43 and leads to its total loss of function as seen by changes in the alternative splicing of endogenous genes. In this work, we further characterize this model and show the importance of the N-terminus structure in the loss of function process. In addition, from a biochemical point of view we report that, as shown in a previous version of this model (GFP 12 × Q/N), the endogenous TDP-43 trapped in the aggregates undergoes the 2 most important post-translational modifications seen in pathological TDP-43 inclusions: ubiquitination and hyperphosphorylation.

Entities:  

Keywords:  ALS; ALS, amyotrophic lateral sclerosis; FTD, frontemportal dementia; GFP, green fluorescent protein; RRM, RNA recognition motif; TDP-43; TDP-43, TAR DNA binding protein 43; Ub-HA, Ubiquitin-HA; hnRNP, heterogeneous ribonucleoproteins; post-translational modifications; prion; protein aggregation

Mesh:

Substances:

Year:  2015        PMID: 25635624      PMCID: PMC4601194          DOI: 10.1080/19336896.2015.1011885

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  25 in total

1.  "Structural characterization of the minimal segment of TDP-43 competent for aggregation".

Authors:  Miguel Mompeán; Emanuele Buratti; Corrado Guarnaccia; Rui M M Brito; Avijit Chakrabartty; Francisco E Baralle; Douglas V Laurents
Journal:  Arch Biochem Biophys       Date:  2014-01-15       Impact factor: 4.013

2.  Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43.

Authors:  Rodrigo A Fuentealba; Maria Udan; Shaughn Bell; Iga Wegorzewska; Jieya Shao; Marc I Diamond; Conrad C Weihl; Robert H Baloh
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

3.  TDP-43 N terminus encodes a novel ubiquitin-like fold and its unfolded form in equilibrium that can be shifted by binding to ssDNA.

Authors:  Haina Qin; Liang-Zhong Lim; Yuanyuan Wei; Jianxing Song
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-12       Impact factor: 11.205

4.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

5.  TDP-43 regulates its mRNA levels through a negative feedback loop.

Authors:  Youhna M Ayala; Laura De Conti; S Eréndira Avendaño-Vázquez; Ashish Dhir; Maurizio Romano; Andrea D'Ambrogio; James Tollervey; Jernej Ule; Marco Baralle; Emanuele Buratti; Francisco E Baralle
Journal:  EMBO J       Date:  2010-12-03       Impact factor: 11.598

6.  Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.

Authors:  Pablo Arrisi Mercado; Youhna M Ayala; Maurizio Romano; Emanuele Buratti; Francisco E Baralle
Journal:  Nucleic Acids Res       Date:  2005-10-27       Impact factor: 16.971

7.  TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain.

Authors:  Mauricio Budini; Valentina Romano; Zainuddin Quadri; Emanuele Buratti; Francisco E Baralle
Journal:  Hum Mol Genet       Date:  2014-08-13       Impact factor: 6.150

8.  Structural determinants of the cellular localization and shuttling of TDP-43.

Authors:  Youhna M Ayala; Paola Zago; Andrea D'Ambrogio; Ya-Fei Xu; Leonard Petrucelli; Emanuele Buratti; Francisco E Baralle
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

9.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 10.  Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.

Authors:  Nicolas Dzamko; Jinxia Zhou; Yue Huang; Glenda M Halliday
Journal:  Front Mol Neurosci       Date:  2014-06-24       Impact factor: 5.639

View more
  17 in total

Review 1.  Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.

Authors:  Lin Guo; James Shorter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-09-01       Impact factor: 6.915

2.  Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.

Authors:  Miguel Mompeán; Valentina Romano; David Pantoja-Uceda; Cristiana Stuani; Francisco E Baralle; Emanuele Buratti; Douglas V Laurents
Journal:  J Biol Chem       Date:  2017-05-31       Impact factor: 5.157

3.  Poly(ADP-Ribose) Prevents Pathological Phase Separation of TDP-43 by Promoting Liquid Demixing and Stress Granule Localization.

Authors:  Leeanne McGurk; Edward Gomes; Lin Guo; Jelena Mojsilovic-Petrovic; Van Tran; Robert G Kalb; James Shorter; Nancy M Bonini
Journal:  Mol Cell       Date:  2018-08-09       Impact factor: 17.970

4.  A novel Drosophila model of TDP-43 proteinopathies: N-terminal sequences combined with the Q/N domain induce protein functional loss and locomotion defects.

Authors:  Simona Langellotti; Valentina Romano; Giulia Romano; Raffaella Klima; Fabian Feiguin; Lucia Cragnaz; Maurizio Romano; Francisco E Baralle
Journal:  Dis Model Mech       Date:  2016-04-21       Impact factor: 5.758

5.  An Amyloid-Like Pathological Conformation of TDP-43 Is Stabilized by Hypercooperative Hydrogen Bonds.

Authors:  Miguel Mompeán; Marco Baralle; Emanuele Buratti; Douglas V Laurents
Journal:  Front Mol Neurosci       Date:  2016-11-17       Impact factor: 5.639

6.  Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells.

Authors:  Chiara Appocher; Fatemeh Mohagheghi; Sara Cappelli; Cristiana Stuani; Maurizio Romano; Fabian Feiguin; Emanuele Buratti
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

7.  The N-terminal dimerization is required for TDP-43 splicing activity.

Authors:  Lei-Lei Jiang; Wei Xue; Jun-Ye Hong; Jun-Ting Zhang; Min-Jun Li; Shao-Ning Yu; Jian-Hua He; Hong-Yu Hu
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

8.  Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation.

Authors:  Tariq Afroz; Eva-Maria Hock; Patrick Ernst; Chiara Foglieni; Melanie Jambeau; Larissa A B Gilhespy; Florent Laferriere; Zuzanna Maniecka; Andreas Plückthun; Peer Mittl; Paolo Paganetti; Frédéric H T Allain; Magdalini Polymenidou
Journal:  Nat Commun       Date:  2017-06-29       Impact factor: 14.919

Review 9.  Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72.

Authors:  Mauricio Budini; Emanuele Buratti; Eugenia Morselli; Alfredo Criollo
Journal:  Front Mol Neurosci       Date:  2017-05-30       Impact factor: 5.639

10.  Translation of the focus toward excellence in translational science: comment on "TDP-43 Repression of Nonconserved Cryptic Exons is Compromised in ALS-FTD".

Authors:  Roland Pochet; Charles Nicaise; Dinko Mitrečić
Journal:  Croat Med J       Date:  2015-10       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.